| Name | Fred Meyer Pharmacy #651 |
|---|---|
| Organization Name | Fred Meyer Stores Inc |
| Location | 1401 Se 1st Ave, Canby, Oregon 97013 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (503) 264-4128 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
By now, Americans everywhere are receiving premium increases and new policy choices when it comes to healthcare. Subscribers' rates are increasing and companies are making decisions about what they plan to do with the rising costs heading their way, says Frank N. Darras, the nation's top insurance lawyer.
The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.
A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal rhythm and a moderately prolonged QRS complex as demonstrated on EKG.
› Verified 8 days ago
| NPI Number | 1821034737 |
| Organization Name | FRED MEYER STORES INC |
| Doing Business As | FRED MEYER PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1401 Se 1st Ave, Canby, OR 97013 |
| Phone Number | 503-263-4128 |
News Archive
Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
By now, Americans everywhere are receiving premium increases and new policy choices when it comes to healthcare. Subscribers' rates are increasing and companies are making decisions about what they plan to do with the rising costs heading their way, says Frank N. Darras, the nation's top insurance lawyer.
The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.
A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal rhythm and a moderately prolonged QRS complex as demonstrated on EKG.
› Verified 8 days ago
News Archive
Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
By now, Americans everywhere are receiving premium increases and new policy choices when it comes to healthcare. Subscribers' rates are increasing and companies are making decisions about what they plan to do with the rising costs heading their way, says Frank N. Darras, the nation's top insurance lawyer.
The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.
A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal rhythm and a moderately prolonged QRS complex as demonstrated on EKG.
› Verified 8 days ago
Fred Meyer Pharmacy #651 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1401 Se 1st Ave, Canby, Oregon 97013 Phone: (503) 264-4128 | |
Rite Aid Pharmacy 05325 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 891 Se 1st Ave, Canby, Oregon 97013 Phone: (503) 266-6381 | |
Walgreens #10893 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1080 Sw 1st Ave, Canby, Oregon 97013 Phone: (503) 263-1600 |